Key facts
- Civik Biotech’s last known valuation is $7.8M (Apr 2026).
- It has raised $850K across 1 recorded rounds; the latest was Seed Round ($850K) in Apr 2026.
- Civik Biotech has filed 1 Form D with the SEC, most recently Apr 2026 ($850K sold to 8 investors).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Civik Biotech
Create free account
No card required
Funding rounds
1 roundsAbout Civik Biotech
Operator of a biotech company based in Kirkland, Washington. The company is currently operating in stealth mode.
- Sector
- Healthcare
- HQ
- Kirkland, WA, United States
- Founded
- 2026
- Website
- civikbiotech.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
Civik Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Civik Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Civik Biotech in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.